These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9846621

  • 1. Lp82 calpain during rat lens maturation and cataract formation.
    Shearer TR, Ma H, Shih M, Hata I, Fukiage C, Nakamura Y, Azuma M.
    Curr Eye Res; 1998 Nov; 17(11):1037-43. PubMed ID: 9846621
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lp85 calpain is an enzymatically active rodent-specific isozyme of lens Lp82.
    Ma H, Shih M, Hata I, Fukiage C, Azuma M, Shearer TR.
    Curr Eye Res; 2000 Mar; 20(3):183-9. PubMed ID: 10694893
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical properties of lens-specific calpain Lp85.
    Shih M, Ma H, Nakajima E, David LL, Azuma M, Shearer TR.
    Exp Eye Res; 2006 Jan; 82(1):146-52. PubMed ID: 16054132
    [Abstract] [Full Text] [Related]

  • 9. Influence of specific regions in Lp82 calpain on protein stability, activity, and localization within lens.
    Ma H, Shih M, Fukiage C, Azuma M, Duncan MK, Reed NA, Richard I, Beckmann JS, Shearer TR.
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4232-9. PubMed ID: 11095620
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decreased sensitivity of lens-specific calpain Lp82 to calpastatin inhibitor.
    Nakamura Y, Fukiage C, Ma H, Shih M, Azuma M, Shearer TR.
    Exp Eye Res; 1999 Aug; 69(2):155-62. PubMed ID: 10433852
    [Abstract] [Full Text] [Related]

  • 12. Contribution of calpain Lp82-induced proteolysis to experimental cataractogenesis in mice.
    Nakamura Y, Fukiage C, Shih M, Ma H, David LL, Azuma M, Shearer TR.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1460-6. PubMed ID: 10798663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cataract and the acceleration of calpain-induced beta-crystallin insolubilization occurring during normal maturation of rat lens.
    David LL, Azuma M, Shearer TR.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):785-93. PubMed ID: 8125740
    [Abstract] [Full Text] [Related]

  • 18. Amelioration of cataracts and proteolysis in cultured lenses by cysteine protease inhibitor E64.
    Shearer TR, Azuma M, David LL, Murachi T.
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):533-40. PubMed ID: 1848210
    [Abstract] [Full Text] [Related]

  • 19. Protein expression patterns for ubiquitous and tissue specific calpains in the developing mouse lens.
    Reed NA, Castellini MA, Ma H, Shearer TR, Duncan MK.
    Exp Eye Res; 2003 Apr; 76(4):433-43. PubMed ID: 12634108
    [Abstract] [Full Text] [Related]

  • 20. Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats.
    Tamada Y, Fukiage C, Mizutani K, Yamaguchi M, Nakamura Y, Azuma M, Shearer TR.
    Curr Eye Res; 2001 Apr; 22(4):280-5. PubMed ID: 11462167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.